Comparing two liver scanners for chronic liver disease
Part of Digestive system, Infections clinical trials.
This study compares a handheld scanner (elastography device) with a standard scanner (iLivTouch) to measure liver stiffness in people with chronic hepatitis B, fatty liver disease, or related cirrhosis. The goal is to see how well the handheld device works, which could make liver testing easier and more accessible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have chronic hepatitis B or related liver cirrhosis, or you have metabolic fatty liver disease or related liver damage.
- You do not have other liver diseases like alcoholic liver disease or autoimmune hepatitis.
- You do not have advanced liver problems like fluid in the belly or confusion.
- You do not have liver cancer or large liver cysts.
- You are not pregnant.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study follows people with a type of fatty liver disease called MAFLD to see if a reliable, painless ultrasound test called iLivTouch can help predict future liver problems. This could help doctors know who needs closer monitoring.
This trial tests a new wearable patch that uses ultrasound to measure liver stiffness, which can help diagnose scarring. It may be an option if you already need or recently had a FibroScan for chronic liver disease.
This study tests whether a new scoring method can help doctors identify liver inflammation in patients who have both type 2 diabetes and a fatty liver. The goal is to find an easier, safer way to assess liver health without invasive procedures.
This study compares two non-invasive ultrasound methods (EUS-SWQ and FibroScan) with liver biopsy to see how well they detect liver scarring in patients with chronic liver disease. The goal is to improve how doctors diagnose and monitor liver damage from conditions like hepatitis B and fatty liver disease.
This study uses a special ultrasound technique, called shear wave elastography, to measure liver stiffness during an endoscopic ultrasound (EUS) procedure. It aims to see how well this new method detects liver scarring (fibrosis) in people with fatty liver disease, compared to standard tests like FibroScan and liver biopsy.
This study tests a new way to measure liver scarring using a non-invasive ultrasound of the spleen (spleen stiffness measurement). It's for people with fatty liver disease (MASLD) who have advanced fibrosis (scarring) to see if this method can accurately detect the severity of liver damage.
Hear when a new MAFLD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.